Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice.

Galliverti G, Tichet M, Domingos-Pereira S, Hauert S, Nardelli-Haefliger D, Swartz MA, Hanahan D, Wullschleger S.

Cancer Immunol Res. 2018 Aug 21. doi: 10.1158/2326-6066.CIR-18-0166. [Epub ahead of print]

PMID:
30131378
2.

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

Chevalier MF, Trabanelli S, Racle J, Salomé B, Cesson V, Gharbi D, Bohner P, Domingos-Pereira S, Dartiguenave F, Fritschi AS, Speiser DE, Rentsch CA, Gfeller D, Jichlinski P, Nardelli-Haefliger D, Jandus C, Derré L.

J Clin Invest. 2017 Aug 1;127(8):2916-2929. doi: 10.1172/JCI89717. Epub 2017 Jun 26.

3.

Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.

Domingos-Pereira S, Cesson V, Chevalier MF, Derré L, Jichlinski P, Nardelli-Haefliger D.

Oncoimmunology. 2016 Dec 7;6(1):e1265720. doi: 10.1080/2162402X.2016.1265720. eCollection 2017.

4.

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.

Hojeij R, Domingos-Pereira S, Nkosi M, Gharbi D, Derré L, Schiller JT, Jichlinski P, Nardelli-Haefliger D.

Int J Mol Sci. 2016 Jul 14;17(7). pii: E1125. doi: 10.3390/ijms17071125.

5.

Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion.

Alonso F, Domingos-Pereira S, Le Gal L, Derré L, Meda P, Jichlinski P, Nardelli-Haefliger D, Haefliger JA.

Oncotarget. 2016 Mar 22;7(12):14015-28. doi: 10.18632/oncotarget.7370.

6.

Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.

Domingos-Pereira S, Hojeij R, Reggi E, Derré L, Chevalier MF, Romero P, Jichlinski P, Nardelli-Haefliger D.

Oncoimmunology. 2015 May 22;4(7):e1016697. eCollection 2015 Jul.

7.

Immunotherapeutic strategies for bladder cancer.

Chevalier MF, Nardelli-Haefliger D, Domingos-Pereira S, Jichlinski P, Derré L.

Hum Vaccin Immunother. 2014;10(4):977-81. Epub 2014 Jan 2.

8.

Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.

Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D.

J Urol. 2014 Mar;191(3):814-22. doi: 10.1016/j.juro.2013.08.009. Epub 2013 Aug 13.

PMID:
23954582
9.

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cells.

Decrausaz L, Pythoud C, Domingos-Pereira S, Derré L, Jichlinski P, Nardelli-Haefliger D.

Oncoimmunology. 2013 Jan 1;2(1):e22944.

10.

Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.

Domingos-Pereira S, Decrausaz L, Derré L, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D.

Mucosal Immunol. 2013 Mar;6(2):393-404. doi: 10.1038/mi.2012.83. Epub 2012 Sep 12.

11.

Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D.

Int J Cancer. 2011 Aug 1;129(3):762-72. doi: 10.1002/ijc.25973.

12.

A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.

Decrausaz L, Gonçalves AR, Domingos-Pereira S, Pythoud C, Stehle JC, Schiller J, Jichlinski P, Nardelli-Haefliger D.

Int J Cancer. 2011 May 1;128(9):2105-13. doi: 10.1002/ijc.25561.

Supplemental Content

Loading ...
Support Center